Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
16.61
-0.04 (-0.24%)
Feb 11, 2026, 4:00 PM EST - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $516.01 million as of February 11, 2026. Its market cap has increased by 344.95% in one year.
Market Cap
516.01M
Enterprise Value
373.15M
1-Year Change
344.95%
Ranking
Category
Stock Price
$16.61
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $516.01M, a decrease of -2.40%. That is a compound annual growth rate of -1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 517.25M | -6.46% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 539.92M |
| Gossamer Bio | 539.29M |
| Ginkgo Bioworks Holdings | 524.60M |
| Forte Biosciences | 523.17M |
| Keros Therapeutics | 522.49M |
| Tenax Therapeutics | 518.89M |
| Lexeo Therapeutics | 513.83M |
| Neumora Therapeutics | 508.12M |